BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan W, Chen L, Wu X, Zhang T. Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis. Cancer Manag Res 2021;13:743-55. [PMID: 33531841 DOI: 10.2147/CMAR.S272851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Niu ZS, Wang WH. Circular RNAs in hepatocellular carcinoma: Recent advances. World J Gastrointest Oncol 2022; 14(6): 1067-1085 [DOI: 10.4251/wjgo.v14.i6.1067] [Reference Citation Analysis]
2 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
3 Lin JC, Zhu NX, Wu LF. Research progress of circRNAs in chemotherapy resistance of digestive system neoplasms. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1237-1247 [DOI: 10.11569/wcjd.v29.i21.1237] [Reference Citation Analysis]
4 Mu Q, Lv Y, Luo C, Liu X, Huang C, Xiu Y, Tang L. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. Front Pharmacol 2021;12:709324. [PMID: 34566636 DOI: 10.3389/fphar.2021.709324] [Reference Citation Analysis]
5 Xu XF, Yang XK, Song Y, Chen BJ, Yu X, Xu T, Chen ZL. Dysregulation of Non-coding RNAs mediates Cisplatin Resistance in Hepatocellular Carcinoma and therapeutic strategies. Pharmacol Res 2021;:105906. [PMID: 34543740 DOI: 10.1016/j.phrs.2021.105906] [Reference Citation Analysis]
6 Liao R, Liu L, Zhou J, Wei X, Huang P. Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. Front Oncol 2021;11:697747. [PMID: 34277444 DOI: 10.3389/fonc.2021.697747] [Reference Citation Analysis]